Legal & General Group Plc Buys Shares of 1,968,875 Cigna Group $CI

Legal & General Group Plc purchased a new stake in shares of Cigna Group (NYSE:CI) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 1,968,875 shares of the health services provider’s stock, valued at approximately $542,779,000. Legal & General Group Plc owned 0.75% of Cigna Group as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also modified their holdings of CI. Wilkerson Advisory Group LLC acquired a new position in Cigna Group during the 4th quarter valued at about $25,000. Osbon Capital Management LLC bought a new position in Cigna Group in the 2nd quarter worth about $26,000. Cedar Mountain Advisors LLC increased its stake in shares of Cigna Group by 161.9% in the first quarter. Cedar Mountain Advisors LLC now owns 110 shares of the health services provider’s stock valued at $29,000 after purchasing an additional 68 shares during the period. Johnson Financial Group Inc. bought a new stake in shares of Cigna Group during the second quarter valued at approximately $29,000. Finally, Fiduciary Financial Advisors bought a new stake in shares of Cigna Group during the second quarter valued at approximately $29,000. Institutional investors own 86.99% of the company’s stock.

Insider Activity

In other news, insider Nicole S. Jones sold 2,677 shares of Cigna Group stock in a transaction that occurred on Tuesday, August 18th. The shares were sold at an average price of $279.61, for a total value of $748,515.97. Following the transaction, the insider directly owned 25,880 shares of the company’s stock, valued at $7,236,306.80. This trade represents a 9.37% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Jamie G. Kates sold 899 shares of the business’s stock in a transaction that occurred on Friday, June 12th. The shares were sold at an average price of $298.61, for a total transaction of $268,450.39. Following the sale, the chief accounting officer owned 2,368 shares in the company, valued at $707,108.48. This represents a 27.52% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders have sold 23,012 shares of company stock worth $6,386,550. Corporate insiders own 0.60% of the company’s stock.

Cigna Group Stock Performance

CI opened at $280.32 on Tuesday. The company has a quick ratio of 0.76, a current ratio of 0.76 and a debt-to-equity ratio of 0.68. The firm has a market cap of $74.07 billion, a PE ratio of 11.60, a P/E/G ratio of 0.95 and a beta of 0.29. The business has a fifty day simple moving average of $283.92 and a 200-day simple moving average of $281.48. Cigna Group has a fifty-two week low of $239.51 and a fifty-two week high of $315.47.

Cigna Group (NYSE:CI) last announced its earnings results on Thursday, July 30th. The health services provider reported $7.78 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.60 by $0.18. Cigna Group had a return on equity of 19.75% and a net margin of 2.27%.The company had revenue of $70.04 billion for the quarter, compared to analyst estimates of $70.14 billion. During the same period in the previous year, the firm earned $7.20 earnings per share. Cigna Group’s revenue for the quarter was up 6.7% compared to the same quarter last year. Cigna Group has set its FY 2026 guidance at 30.450- EPS. As a group, equities analysts predict that Cigna Group will post 30.51 EPS for the current fiscal year.

Cigna Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 23rd. Shareholders of record on Tuesday, September 8th will be issued a dividend of $1.56 per share. This represents a $6.24 annualized dividend and a yield of 2.2%. The ex-dividend date is Tuesday, September 8th. Cigna Group’s payout ratio is presently 25.82%.

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on CI. UBS Group increased their price objective on Cigna Group from $375.00 to $400.00 and gave the stock a “buy” rating in a report on Friday, May 22nd. Piper Sandler cut their target price on Cigna Group from $370.00 to $346.00 and set an “overweight” rating on the stock in a research note on Wednesday, June 3rd. Guggenheim boosted their price target on Cigna Group from $338.00 to $361.00 and gave the stock a “buy” rating in a research report on Friday, July 31st. Deutsche Bank Aktiengesellschaft lowered Cigna Group from a “buy” rating to a “hold” rating and lowered their price target for the company from $303.00 to $302.00 in a report on Wednesday, May 20th. Finally, The Goldman Sachs Group lifted their price objective on shares of Cigna Group from $335.00 to $340.00 and gave the company a “buy” rating in a research note on Monday, May 4th. Fifteen equities research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $339.45.

About Cigna Group

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.